XTNT: Xtant Medical Holdings, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 112.49
Enterprise Value ($M) 128.57
Book Value ($M) 51.35
Book Value / Share 0.39
Price / Book 2.19
NCAV ($M) 23.61
NCAV / Share 0.18
Price / NCAV 4.77

Profitability (mra)
Return on Invested Capital (ROIC) 0.01
Return on Assets (ROA) 0.01
Return on Equity (ROE) 0.02

Liquidity (mrq)
Quick Ratio 1.22
Current Ratio 2.82

Balance Sheet (mrq) ($M)
Current Assets 64.87
Assets 92.61
Liabilities 41.26
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 91.30
Operating Income -10.16
Net Income 0.66
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -9.52
Cash from Investing -24.78
Cash from Financing 19.69

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Altium Capital Management LP 6.20 28.52
08-03 13D/A Orbimed Advisors Llc 56.70 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 27,558 273,702 10.07
2024-05-02 3,992 67,343 5.93
2024-05-01 12,056 27,509 43.83
2024-04-30 10,142 36,184 28.03
2024-04-29 1,166 53,497 2.18

(click for more detail)

Similar Companies
TOVX – Theriva Biologics, Inc. VCXB – 10X Capital Venture Acquisition Corp. III
VNRX – VolitionRx Limited


Financial data and stock pages provided by
Fintel.io


Finpedia: Xtant Medical Holdings